Drucken
Marktanalyse - Calming and Sleeping in the US
Euromonitor
4 / 2012
47 Seiten
| Typ: | Marktanalyse |
| Sprache: | Englisch |
| Regionen: | United States |
| Verfügbarkeit: | verfügbar |
Bitte wählen Sie ein Lieferformat und klicken Sie unten auf einen Bestellbutton:
In January 2010, McNeil recalled nine lots of its leading brand Simply Sleep. In the following years, consumers reported that the brand had totally vanished from store shelves, forcing them to buy other brands or private label alternatives. The duration of this product’s disappearance devastated sales, and as of February 2012 the company’s website stated '[Simply Sleep] is currently not available on store shelves. To be alerted when TYLENOL® Simply Sleep becomes available, please sign up to...
Euromonitor International's Calming and Sleeping in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Calming and Sleeping market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago and Sydney and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Euromonitor International's Calming and Sleeping in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Calming and Sleeping market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago and Sydney and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
CALMING AND SLEEPING IN THE US
Euromonitor International
April 2012
LIST OF CONTENTS AND TABLES
Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Calming and Sleeping: Value 2006-2011
Table 2 Sales of Calming and Sleeping: % Value Growth 2006-2011
Table 3 Calming and Sleeping Company Shares by Value 2007-2011
Table 4 Calming and Sleeping Brand Shares by Value 2008-2011
Table 5 Forecast Sales of Calming and Sleeping: Value 2011-2016
Table 6 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016
Chattem Inc in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 1 Chattem Inc: Key Facts
Company Background
Production
Competitive Positioning
Summary 2 Chattem Inc: Competitive Position 2011
Cvs Caremark Corp in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 3 CVS Caremark Corp: Key Facts
Summary 4 CVS Caremark Corp: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 5 CVS Caremark Corp: Competitive Position 2011
GlaxoSmithKline Consumer Health in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 6 GlaxoSmithKline Consumer Health: Key Facts
Company Background
Production
Competitive Positioning
Summary 7 GlaxoSmithKline Consumer Health: Competitive Position 2011
Mcneil Consumer & Specialty Pharmaceuticals in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 8 McNeil Consumer & Specialty Pharmaceuticals: Key Facts
Summary 9 McNeil Consumer & Specialty Pharmaceuticals: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 10 McNeil Consumer & Specialty Pharmaceuticals: Competitive Position 2011
Pfizer Consumer Healthcare Inc in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 11 Pfizer Consumer Healthcare Inc: Key Facts
Company Background
Production
Competitive Positioning
Summary 12 Pfizer Consumer Healthcare Inc: Competitive Position 2011
Walgreen Co in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 13 Walgreen Co: Key Facts
Summary 14 Walgreen Co: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 15 Walgreen Co: Competitive Position 2011
Executive Summary
Consumer Health Sales Hit All-time High
Vitamins and Dietary Supplements Performs the Best
No End in Sight for Recalls
Distribution Continues To Consolidate
Growth Expected To Slow As Categories Mature, Sluggish Economy Persists
Key Trends and Developments
Persistent Recalls Define Another Year in OTC
Acquisitions Shake Up OTC Competitive Landscape
Increasing Media Attention Drives Supplementation Fever
Growing Mainstream Appeal Catapults Sports Nutrition Sales
Tonics and Bottled Nutritive Drinks: the New Mega-category
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 8 Life Expectancy at Birth 2006-2011
Market Data
Table 9 Sales of Consumer Health by Category: Value 2006-2011
Table 10 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 11 Consumer Health Company Shares 2007-2011
Table 12 Consumer Health Brand Shares 2008-2011
Table 13 Penetration of Private Label by Category 2006-2011
Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 16 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 16 OTC - Switches 2009-2011
Sources
Summary 17 Research Sources
Euromonitor International
April 2012
LIST OF CONTENTS AND TABLES
Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Calming and Sleeping: Value 2006-2011
Table 2 Sales of Calming and Sleeping: % Value Growth 2006-2011
Table 3 Calming and Sleeping Company Shares by Value 2007-2011
Table 4 Calming and Sleeping Brand Shares by Value 2008-2011
Table 5 Forecast Sales of Calming and Sleeping: Value 2011-2016
Table 6 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016
Chattem Inc in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 1 Chattem Inc: Key Facts
Company Background
Production
Competitive Positioning
Summary 2 Chattem Inc: Competitive Position 2011
Cvs Caremark Corp in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 3 CVS Caremark Corp: Key Facts
Summary 4 CVS Caremark Corp: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 5 CVS Caremark Corp: Competitive Position 2011
GlaxoSmithKline Consumer Health in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 6 GlaxoSmithKline Consumer Health: Key Facts
Company Background
Production
Competitive Positioning
Summary 7 GlaxoSmithKline Consumer Health: Competitive Position 2011
Mcneil Consumer & Specialty Pharmaceuticals in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 8 McNeil Consumer & Specialty Pharmaceuticals: Key Facts
Summary 9 McNeil Consumer & Specialty Pharmaceuticals: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 10 McNeil Consumer & Specialty Pharmaceuticals: Competitive Position 2011
Pfizer Consumer Healthcare Inc in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 11 Pfizer Consumer Healthcare Inc: Key Facts
Company Background
Production
Competitive Positioning
Summary 12 Pfizer Consumer Healthcare Inc: Competitive Position 2011
Walgreen Co in Consumer Health (usa)
Strategic Direction
Key Facts
Summary 13 Walgreen Co: Key Facts
Summary 14 Walgreen Co: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 15 Walgreen Co: Competitive Position 2011
Executive Summary
Consumer Health Sales Hit All-time High
Vitamins and Dietary Supplements Performs the Best
No End in Sight for Recalls
Distribution Continues To Consolidate
Growth Expected To Slow As Categories Mature, Sluggish Economy Persists
Key Trends and Developments
Persistent Recalls Define Another Year in OTC
Acquisitions Shake Up OTC Competitive Landscape
Increasing Media Attention Drives Supplementation Fever
Growing Mainstream Appeal Catapults Sports Nutrition Sales
Tonics and Bottled Nutritive Drinks: the New Mega-category
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 8 Life Expectancy at Birth 2006-2011
Market Data
Table 9 Sales of Consumer Health by Category: Value 2006-2011
Table 10 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 11 Consumer Health Company Shares 2007-2011
Table 12 Consumer Health Brand Shares 2008-2011
Table 13 Penetration of Private Label by Category 2006-2011
Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 16 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 16 OTC - Switches 2009-2011
Sources
Summary 17 Research Sources
- Calming and Sleeping in Argentina
- Calming and Sleeping in Canada
- Calming and Sleeping in Denmark
- Calming and Sleeping in Guatemala
- Calming and Sleeping in Hong Kong, China
- Calming and Sleeping in Norway
- Calming and Sleeping in Turkey
- Cough, Cold and Allergy (Hay Fever) Remedies in Argentina
- Cough, Cold and Allergy (Hay Fever) Remedies in Canada
- Cough, Cold and Allergy (Hay Fever) Remedies in Denmark
- Cough, Cold and Allergy (Hay Fever) Remedies in Guatemala
- Cough, Cold and Allergy (Hay Fever) Remedies in Hong Kong, China
- Cough, Cold and Allergy (Hay Fever) Remedies in Norway
- Cough, Cold and Allergy (Hay Fever) Remedies in Tunisia
- Cough, Cold and Allergy (Hay Fever) Remedies in Turkey
- Critical Care Market to 2019 - Growth from Factor Concentrates New Indications and Increasing Demand for Albumin in Asia-Pacific
- Ear Care in Argentina
- Ear Care in Canada
- Ear Care in Denmark
- Ear Care in Hong Kong, China
*Alle Preise sind netto ausgewiesen. In Abhängigkeit von Ihrer Rechnungsanschrift ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Unser Angebot richtet sich ausschließlich an Unternehmen, Gewerbetreibende und Freiberufler.
Für Sie protokollierte Studien / Marktanalysen:
zuletzt angesehene Studien: